The FDA is weighing the pros and cons of a drug that would, for the first time, combine morphine and oxycodone in a single pill. Critics warn it could launch a new wave of abuse.
A shadow campaign is underway, raising small donations by selling T-shirts and baby onesies and holding fundraisers, all just waiting for Clinton to say that, yes, she is running for president.
Street dogs and cats find treatment and get linked up with foreign adopters at a clinic that's helping lower the rabies threat in Kabul.
For the first time in six years, many California farmers have been told they'll get little or no federal irrigation water. And as farms run dry, workers are deciding to pack up and move away.
The Ballad of a Small Player is set in the murky underworld of Macau's casinos. Reviewer Tash Aw calls the novel a masterful and thrilling collision of old Asia and 21st century glamour.
The quest for cheap, reliable electricity to power enormous cloud computing facilities is sending tech companies to the ends of the earth.
In Colorado, where recreational pot is now legal, stores are working hard to stand out — marketing to fans of organic, locally grown produce and trying to liken using pot to enjoying a glass of wine.
The proposal awaiting the governor's signature has bipartisan support, despite doctors' opposition. Critics say it could deter expectant mothers from seeking help, or even encourage more abortions.
The killing of three people at a checkpoint in the eastern Ukrainian city of Slaviansk has increased tension in the town, where a government building is being occupied by pro-Moscow militants.
The Boston Marathon is back, over one year since bombs rocked its finish line. NPR's Jeff Brady discusses the race, its heightened security and Meb Keflezighi, the first American to win it since 1983.